Sun Pharma gains 5% as Sebi finds no merit in allegation of fraud https://ift.tt/eA8V8J - Walletnews For Me

News regarding money,markets and finance

Breaking

Home Top Ad

Post Top Ad

Responsive Ads Here

Wednesday, August 28, 2019

Sun Pharma gains 5% as Sebi finds no merit in allegation of fraud https://ift.tt/eA8V8J

HDFC Securities has 'buy' rating on Sun Pharma with a 12-month target price of Rs 545 as the brokerage expects a recovery in the profitability (24 per cent margin) by FY21E.
Markets
https://ift.tt/2zuAICe

No comments:

Post a Comment

Post Bottom Ad

Responsive Ads Here

Pages